Showing posts with label Womens Health. Show all posts
Showing posts with label Womens Health. Show all posts

Saturday, January 29, 2011

Hormone therapy and breast cancer risk news

Earlier Hormone Therapy Elevates Risk of Breast Cancer, Researchers Say - New York Times -

Waiting to take HRT 'lessens breast cancer effect' - Telegraph.co.uk

Starting HRT early raises breast cancer risk: study – Reuters

Hot flashes, night sweats may reduce breast cancer risk - Washington Post

Why Those Agonizing Hot Flashes May Not Be All Bad – TIME

Delaying Hormone Use Cuts Breast Cancer Risk - MedPage Today

Thursday, January 13, 2011

Polycystic ovary syndrome (PCOS) and Bisphenol A

Women with polycystic ovary syndrome (PCOS) have higher levels of Bisphenol A (BPA) and excessive secretion of androgens. Risk of obesity, type 2 diabetes, heart disease and infertility also increases in patients with PCOS. Therefore a healthy diet, exercise, and oral contraceptives are reasonable preventative therapies.

Learn more about PCOS: http://www.pcosupport.org/med_treatments.php

Reference:

E. Kandaraki, A. Chatzigeorgiou, S. Livadas, E. Palioura, F. Economou, M. Koutsilieris, S. Palimeri, D. Panidis, E. Diamanti-Kandarakis. Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS. Journal of Clinical Endocrinology & Metabolism

Monday, January 10, 2011

Therapies that stop estrogen from binding to cancer cells

Therapies that stop estrogen from binding to cancer cells

Sunday, January 9, 2011

Revised Guidelines for the Prevention of Perinatal Group B Streptococcal (GBS) Disease

GBS continues is the leader in early-onset sepsis and meningitis in the United States. Therefore, intrapartum antibiotic prophylaxis (IAP) is highly effective.

Revised Guidelines for the Prevention of Perinatal Group B Streptococcal (GBS) Disease

HTML | PDF Adobe PDF file

Reference:

http://www.cdc.gov/groupbstrep/guidelines/guidelines.html

Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of Universal Antenatal Screening for Group B Streptococcus . N Eng J Med. 2009;360(25):2626-36.

Saturday, January 1, 2011

Magnetic resonance-guided focused ultrasound (MRgFUS) to treat Uterine fibroids

Uterine fibroids can be treated with magnetic resonance-guided focused ultrasound (MRgFUS) thus avoiding myomectomy, or hysterectomy. Magnetic resonance imaging (MRI) allows docs to see inside the body by monitoring tissue temperature in real-time. MRgFUS is newer than uterine fibroid embolization (stopping the blood flow to fibroid tumors.)

Reference:

Society of Interventional Radiology (2010, March 15). Interventional radiology: Zapping uterine fibroids with heat from high-energy sound waves. ScienceDaily. Retrieved January 1, 2011, from http://www.sciencedaily.com­ /releases/2010/03/100315103808.htm